Difference between revisions of "Team:IISc Bangalore"

Line 137: Line 137:
 
<div class="content-middle wthree">
 
<div class="content-middle wthree">
 
<div class="container" id="refer">
 
<div class="container" id="refer">
−
<div class="mid-content fadeInRight wow  animated" data-wow-delay=".5s">
+
<!-- <div class="mid-content fadeInRight wow  animated" data-wow-delay=".5s">
 
<h3>The purpose</h3>
 
<h3>The purpose</h3>
−
</div>
+
</div> -->
 
<div class="row">
 
<div class="row">
 
<div class="refer col-md-6">
 
<div class="refer col-md-6">
Line 147: Line 147:
 
</div>
 
</div>
 
<!--content-middle-->
 
<!--content-middle-->
 +
<b>Overview of Our Project</b>
 +
<p class="whitef">With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical  approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009<a href="#refer" onclick="closeTab()">[1]</a>.
 +
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
 +
</p>
 +
 +
<p class="whitef leftMove">We realized that manufacturing units use expensive and energy expensive machinery <a href="#refer" onclick="closeTab()">[3]</a>. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
 +
<br><a href="https://2016.igem.org/Team:IISc_Bangalore/Description"><span class="readm hvr-ripple-out">Read more</span></a>
 +
</p>
 +
 
<br><br>
 
<br><br>
−
<!-- accordian 1 -->
+
<!-- accordian 1
 
<div class="accordion"
 
<div class="accordion"
 
     data-anijs="if: click, on: .heading, do: $removeClass open, to: .open;
 
     data-anijs="if: click, on: .heading, do: $removeClass open, to: .open;
Line 199: Line 208:
  
 
</div>
 
</div>
−
<!-- accordian 1 -->
+
accordian 1 -->
  
 
</div>
 
</div>

Revision as of 19:44, 19 October 2016



Team IISc iGem



Overview of Our Project

With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more

We realized that manufacturing units use expensive and energy expensive machinery [3]. Hence, we engineered our bacteria in such a way that it could do most of the work done by these monstrous machines so that we no longer have to buy them and pay their bills.
Read more